Universal Biosensors, Inc. announced that Dr. Alastair Hodges has resigned by mutual agreement as Chief Scientist with effect April 23, 2018. Dr. Hodges will serve the notice period through mid-July for an orderly transition of responsibilities and UBI and Dr. Hodges will negotiate a consulting agreement under which he will provide consulting and advisory services to UBI following his official departure. In the interim and effective immediately Dr. Peter Newman is appointed as Acting Research Manager and Mr. Luke Cossins is appointed as Acting Research Development Manager working with partner Siemens. Both Dr. Newman and Mr. Cossins are reporting directly to Mr. Legleiter.